» Articles » PMID: 18971273

The Addition of Tumor Necrosis Factor Plus Beta Interferon Induces a Novel Synergistic Antiviral State Against Poxviruses in Primary Human Fibroblasts

Overview
Journal J Virol
Date 2008 Oct 31
PMID 18971273
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor (TNF) and members of the interferon (IFN) family have been shown to independently inhibit the replication of a variety of viruses. In addition, previous reports have shown that treatment with various combinations of these antiviral cytokines induces a synergistic antiviral state that can be significantly more potent than addition of any of these cytokines alone. The mechanism of this cytokine synergy and its effects on global gene expression, however, are not well characterized. Here, we use DNA microarray analysis to demonstrate that treatment of uninfected primary human fibroblasts with TNF plus IFN-beta induces a distinct synergistic state characterized by significant perturbations of several hundred genes which are coinduced by the individual cytokines alone, as well as the induction of more than 850 novel host cell genes. This synergy is mediated directly by the two ligands, not by intermediate secreted factors, and is necessary and sufficient to completely block the productive replication and spread of myxoma virus in human fibroblasts. In contrast, the replication of two other poxviruses, vaccinia virus and tanapox virus, are only partially inhibited in these cells by the synergistic antiviral state, whereas the spread of both of these viruses to neighboring cells was efficiently blocked. Taken together, our data indicate that the combination of TNF and IFN-beta induces a novel synergistic antiviral state that is highly distinct from that induced by either cytokine alone.

Citing Articles

Testing Oncolytic Myxoma Virus in Immunocompetent Mouse Model for Cancer Therapy.

Shakiba Y, Rahman M Methods Mol Biol. 2024; 2860:353-360.

PMID: 39621278 PMC: 11724751. DOI: 10.1007/978-1-0716-4160-6_22.


Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.

Saldajeno D, Kawaoka S, Masuda N, Tanaka S, Bando H, Nishimura T Br J Cancer. 2024; 130(6):1023-1035.

PMID: 38238427 PMC: 10951271. DOI: 10.1038/s41416-023-02527-0.


Cytokine Gene Vaccine Therapy for Treatment of a Brain Tumor.

Lichtor T, Tang B, Roy E Brain Sci. 2023; 13(11).

PMID: 38002466 PMC: 10669932. DOI: 10.3390/brainsci13111505.


Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma.

Ashton L, Weishaar K, Seguin B, MacNeill A Biomedicines. 2023; 11(9).

PMID: 37760788 PMC: 10525839. DOI: 10.3390/biomedicines11092346.


Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.

Lu Y, Michel H, Wang P, Smith G Front Microbiol. 2022; 13:1027015.

PMID: 36478862 PMC: 9720297. DOI: 10.3389/fmicb.2022.1027015.


References
1.
Li C, Wong W . Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001; 98(1):31-6. PMC: 14539. DOI: 10.1073/pnas.98.1.31. View

2.
McFadden G . Poxvirus tropism. Nat Rev Microbiol. 2005; 3(3):201-13. PMC: 4382915. DOI: 10.1038/nrmicro1099. View

3.
Hai T, HARTMAN M . The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene. 2001; 273(1):1-11. DOI: 10.1016/s0378-1119(01)00551-0. View

4.
Samuel C . Antiviral actions of interferons. Clin Microbiol Rev. 2001; 14(4):778-809, table of contents. PMC: 89003. DOI: 10.1128/CMR.14.4.778-809.2001. View

5.
Schuringa J, van der Schaaf S, Vellenga E, Eggen B, Kruijer W . LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells. Exp Cell Res. 2002; 274(1):119-29. DOI: 10.1006/excr.2001.5454. View